title: [Can thymostimulin influence the course of malignant subacute hepatitis?].
authors.forename: S
authors.initials: S
authors.lastname: Tripi
authors.forename: G
authors.initials: G
authors.lastname: Migneco
authors.forename: A
authors.initials: A
authors.lastname: Mascarella
authors.forename: P
authors.initials: P
authors.lastname: Di Marco
authors.forename: C
authors.initials: C
authors.lastname: La Cascia
authors.forename: P
authors.initials: P
authors.lastname: Citarrella
mesh_terms: D000276:Adjuvants, Immunologic / Q000627:therapeutic use*; D000328:Adult; D001706:Biopsy; D005260:Female; D006526:Hepatitis C / Q000175:diagnosis / Q000188:drug therapy* / Q000473:pathology; D006525:Hepatitis, Viral, Human / Q000188:drug therapy*; D006801:Humans; D008099:Liver / Q000473:pathology; D013949:Thymus Extracts / Q000627:therapeutic use*
chemical_list: D000276:Adjuvants, Immunologic; D013949:Thymus Extracts; C031407:thymostimulin
vernacular_title: Può la timostimolina influenzare il decorso dell'epatite sub-acuta maligna?